| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 5.074 | 3.852 | 12.999 | 6.815 |
| Total Income - EUR | - | - | - | - | - | - | 5.074 | 3.852 | 12.999 | 6.815 |
| Total Expenses - EUR | - | - | - | - | - | - | 16 | 6.140 | 8.613 | 12.529 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 5.058 | -2.288 | 4.387 | -5.714 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 4.908 | -2.386 | 3.676 | -5.714 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Afamed Dr. Lazarut S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 9.156 | 7.323 | 5.128 |
| Current Assets | - | - | - | - | - | - | 5.021 | 1.160 | 5.243 | 1.392 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 483 | 0 |
| Receivables | - | - | - | - | - | - | 485 | 112 | 1.799 | 8 |
| Cash | - | - | - | - | - | - | 4.536 | 1.048 | 2.961 | 1.383 |
| Shareholders Funds | - | - | - | - | - | - | 4.949 | 2.578 | 6.246 | -152 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 73 | 7.738 | 6.319 | 6.672 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Afamed Dr. Lazarut S.r.l.